Compass Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Compass Financial Services's PFE Position: Q1 2026 in Review
Compass Financial Services sold out of Pfizer (PFE) in Q1 2026, closing a stake of 70 shares — an estimated $1.75K sold.
Compass Financial Services first reported a position in PFE in Q4 2024 and held it in 5 quarters. The position peaked at $13.9K in Q1 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Compass Financial Services reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Compass Financial Services sold 70 Pfizer shares in Q1 2026, an estimated $1.75K.
- Compass Financial Services first reported a position in Pfizer in Q4 2024 and held it in 5 quarters.
- Compass Financial Services's Pfizer position peaked at $13.9K in Q1 2025.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Compass Financial Services's 13F filing for Q1 2026, filed 1 May 2026.